首页> 外文期刊>Immunology: An Official Journal of the British Society for Immunology >Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages.
【24h】

Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages.

机译:Toll样受体4介导过氧化物酶体增殖物激活的受体γ与巨噬细胞中的核因子-κB之间的串扰。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The peroxisome proliferator-activated receptor gamma (PPARgamma) is expressed in macrophages and plays an important role in suppressing the inflammatory response. Lipopolysaccharides (LPS), which activate Toll-like receptor 4 (TLR4), reduced PPARgamma expression and function in peritoneal macrophages and macrophage cell lines. Moreover, pretreatment with the synthetic PPARgamma ligand, rosiglitazone did not prevent LPS-mediated downregulation of PPARgamma. Inhibition of PPARgamma expression was not blocked by cycloheximide, indicating that de novo protein synthesis is not required for LPS-mediated suppression of PPARgamma. Destabilization of PPARgamma messenger RNA (mRNA) was not observed in LPS-stimulated macrophages, suggesting that LPS regulates the synthesis of PPARgamma mRNA. LPS had no effect on PPARgamma expression in macrophages from TLR4 knockout mice, whereas LPS inhibited PPARgamma expression in cells that had been reconstituted to express functional TLR4. Targeting the TLR4 pathway with inhibitors of MEK1/2, p38, JNK and AP-1 had no effect on PPARgamma downregulation by LPS. However, inhibitors that target NEMO, IkappaB and NF-kappaB abolished LPS-mediated downregulation of PPARgamma in LPS-stimulated macrophages. Our data indicate that activation of TLR4 inhibits PPARgamma mRNA synthesis by an NF-kappaB-dependent mechanism. Low-density genomic profiling of macrophage-specific PPARgamma knockout cells indicated that PPARgamma suppresses inflammation under basal conditions, and that loss of PPARgamma expression is sufficient to induce a proinflammatory state. Our data reveal a regulatory feedback loop in which PPARgamma represses NF-kappaB-mediated inflammatory signalling in unstimulated macrophages; however, upon activation of TLR4, NF-kappaB drives down PPARgamma expression and thereby obviates any potential anti-inflammatory effects of PPARgamma in LPS-stimulated macrophages.
机译:过氧化物酶体增殖物激活受体γ(PPARgamma)在巨噬细胞中表达,在抑制炎症反应中起重要作用。脂多糖(LPS)激活Toll样受体4(TLR4),降低了腹膜巨噬细胞和巨噬细胞细胞系中PPARγ的表达并发挥了作用。此外,用合成的PPARgamma配体罗格列酮进行预处理不能阻止LPS介导的PPARgamma下调。环己酰亚胺未阻止对PPARgamma表达的抑制,这表明从头合成蛋白质不需要LPS介导的PPARgamma抑制。在LPS刺激的巨噬细胞中未观察到PPARgamma信使RNA(mRNA)的失稳,表明LPS调节PPARgamma mRNA的合成。 LPS对TLR4基因敲除小鼠巨噬细胞中PPARγ的表达没有影响,而LPS抑制了重构为表达功能性TLR4的细胞中的PPARγ的表达。用MEK1 / 2,p38,JNK和AP-1抑制剂靶向TLR4途径对LPS对PPARγ的下调没有影响。但是,靶向NEMO,IkappaB和NF-kappaB的抑制剂消除了LPS介导的LPS刺激的巨噬细胞中PPARγ的下调。我们的数据表明,TLR4的激活通过NF-κB依赖性机制抑制PPARgamma mRNA的合成。巨噬细胞特异性PPARgamma敲除细胞的低密度基因组分析表明,PPARgamma可在基础条件下抑制炎症,而PPARgamma表达的丧失足以诱发促炎状态。我们的数据揭示了一种调节性反馈回路,其中PPARgamma抑制未刺激的巨噬细胞中NF-κB介导的炎症信号;但是,在激活TLR4后,NF-κB会降低PPARγ的表达,从而消除LPS刺激的巨噬细胞中PPARγ的任何潜在抗炎作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号